WASHINGTON (October 25, 2004) -– Tomorrow The New York Times will feature a full-page ad by the United States Conference of Catholic Bishops (USCCB) on stem cell research. The ad is part of a nationwide two-week ad campaign by the USCCB aimed at explaining the distinction between embryonic stem cell research, which requires the destruction of human life at the embryonic stage, and adult stem cell research.

"Adult stem cell research is already helping people with many diseases, including heart disease, spinal cord injury, even Parkinson's disease," said Cathy Cleaver Ruse, Esq., Director of Planning and Information for the USCCB's Secretariat for Pro-Life Activities. "By contrast, embryonic stem cell research has not helped one single human patient, and it comes with a hefty price tag: the deliberate destruction of human life."

"As the ads state: science does not have to kill in order to cure," Ruse said.

The ads will appear in The New York Times, USA Today, The Washington Times and the National Catholic Reporter. The ads have also been sent to dioceses nationwide for use in local publications. View the ads at www.usccb.org/prolife/stemcellads.htm

The ads complement an informational flyer, "Stem Cell Research and Human Cloning: Questions and Answers" www.usccb.org/prolife/stemcellQ&A.pdf. Hundreds of thousands of flyers have been distributed through parishes and Catholic organizations across the country.

For media inquiries, e-mail us at commdept@usccb.org
Department of Communications | 3211 4th Street, N.E., Washington DC 20017-1194 | (202) 541-3000 © USCCB. All rights reserved.